NIMR launches US$2m research on monkeypox to avoid its outbreak

NIGERIA – Nigerian Institute of Medical Research (NIMR) has launched CAD$3 million (US$2.22m) research on monkeypox to avert similar disruptions following the outbreak of COVID.

The new project, funded by the Canadian Institute of Health Research, CIHR, and the International Development Research, IDRC will help inform the clinical and public health response to the local and global epidemic of the disease.

Named the Canada-Africa Mpox Partnership, CAMP, the research will bring together 68 researchers with multidisciplinary expertise from Canada, Nigeria, the United States, U.S, the United Kingdom, UK and Co–led by Nigeria’s Prof Rosemary Audu, the Director of Research and Head of Microbiology Department at NIMR.

The Research project would be focusing on three main topics across diverse epidemiological, geo-social and health system contexts of Mpox transmission, treatment and vaccines.

The Director-General of NIMR, Prof Babatunde Salako said that the launch was to introduce the project to critical stakeholders as well as give them the opportunity to share their interests and concerns that can be addressed through the project’s objectives.

Salako said NIMR is working with the Institute of Human Virology, IHVN, University of Ilorin, UNILORIN, among others to ensure it provides needed information for stakeholders and the communities who will be participating in the project.

“Before now, we plan, conduct and disseminate research without involving the community where we want to use those results,” Salako added.

“That has been making it difficult for us to translate new approaches to treatments and new drugs and vaccinations into effective use because the people were not part of it from the beginning.”

Salako regretted that Nigeria has no agency that funds health research like other countries, adding that, like the Canadian Institute, if Nigeria has a similar agency, it would be easy for the country to sort out issues around emerging diseases like monkeypox, Lassa fever, meningitis and others that are breaking.

Co-lead and Director of Research and Head of the Microbiology Department at NIMR, Prof Rosemary Audu, said they decided to respond to the call by the Canadian Institute following the increasing cases of the disease even in the Western world.

She explained that the epidemiology pattern of Mpox from the initial sporadic reports from endemic countries including Nigeria to the sudden surge in non–endemic regions such as Canada calls for more scientific studies on the absence, grey areas and misconstrued aspects of Mpox.

On his part, Chair of the Advisory Board of Research Team and Consultant & Research Professor, NIMR, Prof Richard Adegbola said there was a need for the country to list its priority pathogens and find a way of investigating with a view of nipping them in the bud.

“If you want to solve a problem, you will need to investigate it and study it otherwise you cannot solve the problem,” he said.

“The Canadian wants to know what the problem is in order to stop it and it is time for us as Nigerians to have the list of our priority pathogens so that we don’t wait until when there is a problem.”

Other members of the research team include; Dr Isaac Olufadewa, Country Coordinator, Slum and Rural Health Initiative, Dr Sunday Mogaji, a Clinician, Infectious Disease Unit/Isolation, FMC Ebute- Metta, Senior Research Fellow & Clinician, NIMR, Dr Paschal Ezeobi, Control Component11, Dr Olufemi Daodu, among others.

For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.